Drug intelligence / Profile preview

(6E,11E)-heptadeca-6,11-diene-9,9-diylbis(phosphonic acid)

Development stage
Unknown
Modality
Small Molecules
01

Overview

(6E,11E)-heptadeca-6,11-diene-9,9-diylbis(phosphonic acid) is a synthetic small molecule belonging to the bisphosphonate class. It is structurally characterized by a 17-carbon chain with two phosphonic acid groups at the 9-position and conjugated double bonds at positions 6 and 11. The compound has been studied as an experimental agent and is not approved for clinical use. Its mechanism of action involves inhibition of geranylgeranyl pyrophosphate synthase (GGPS1), an enzyme critical in the biosynthesis of geranylgeranyl pyrophosphate—a key intermediate in protein prenylation pathways. This mechanism suggests potential utility in modulating processes dependent on protein prenylation such as cell signaling or viral replication[3][5][10]. There are no known approved indications or ongoing clinical trials for this compound.

Other names
(6e,11e)-heptadeca-6,11-diene-9,9-diylbis(phosphonic acid)(6E,11E)-6,11-heptadecadiene-9,9-diylbis(phosphonic acid)[(6E,11E)-9-phosphonoheptadeca-6,11-dien-9-yl]phosphonic acid
02

Targets

GGPPS1 (Geranylgeranyl pyrophosphate synthase)

Beyond the preview

Go deeper on (6E,11E)-heptadeca-6,11-diene-9,9-diylbis(phosphonic acid).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (6E,11E)-heptadeca-6,11-diene-9,9-diylbis(phosphonic acid).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call